Business

Latest News

medicare price negotiations and biosimilar development  | Image credit: japhoto - stock.adobe.com
Medicare Price Negotiations Will Slow Biosimilar Momentum, Widening Market Gap

July 16th 2025

Government price negotiations under the Inflation Reduction Act may hinder biosimilar development, impacting drug costs and patient access to affordable therapies.

biosimilar development for biologics coming off patent is limited | Image credit: FUTURESEND - stock.adobe.com
White Paper Offers Tips for Sustaining Biosimilar Progress, Avoiding a Market Void

July 15th 2025

EOP thumbnail
Eye on Pharma: Keytruda Biosimilar Deal; German Court Bans Imraldi; New Biosimilars for Japan

June 17th 2025

health care sales and biosimilars | Image credit: alexkich - stock.adobe.com
Sandoz, STADA, and Samsung Bioepis Report Strong Earnings From Biosimilars

June 10th 2025

savings and biosimilars | Image credit: digicomphoto - stock.adobe.com
Billions in Health Care Savings Realized Through Early Generic, Biosimilar Settlements

June 4th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.